More info
Active ingredients
Camphor + Salicylic Acid + Turpentine Gum + Poison Gyurza
Release form
Ointment
Composition
Active ingredient: Camphor + Salicylic Acid + Gum Turpentine + Viper Venom (Camphora + Acidum salicylicum + Oleum Terebinthinae + Venenum Viperae beri) Active ingredient concentration: 5000 mg
Pharmacological effect
Drug for external use. It has a local irritant and analgesic effect. Causes irritation of sensitive receptors of the skin and subcutaneous tissue, dilates blood vessels, improves tissue trophism.
Pharmacokinetics
Data on the pharmacokinetics of the drug Viprosal B is not provided.
Indications
Neuralgia, arthralgia, myositis.
Contraindications
Increased sensitivity of the skin to ointment components, skin damage, pulmonary tuberculosis, cerebral and coronary circulation disorders, angiospasm tendency, severe liver and kidney dysfunctions, pregnancy, breastfeeding period.
Precautionary measures
Avoid contact with open wounds and mucous membranes.
Use during pregnancy and lactation
The drug is contraindicated for use during pregnancy and lactation (breastfeeding).
Dosage and administration
Locally. Apply 5–10 g on painful areas and rub 1-2 times a day until the pain syndrome disappears. The duration of treatment depends on the nature and severity of the disease.
Side effects
If the skin is sensitive to the components of the ointment, itching, swelling or urticaria may occur. In order to avoid side effects, it is recommended to apply a small amount of ointment to the skin to determine the sensitivity.
Overdose
Data on drug overdose Viprosal B is not provided.
Interaction with other drugs
Data on drug interactions drug Viprosal B is not provided.
special instructions
If any adverse reactions occur, discontinue use of the drug. Use in pediatrics The need for use of the drug in children is determined individually.